176 related articles for article (PubMed ID: 9016869)
21. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
[TBL] [Abstract][Full Text] [Related]
22. Supraphysiological Levels of IL-2 in Jak3-Deficient Mice Promote Strong Proliferative Responses of Adoptively Transferred Naive CD8
Lee GW; Lee SW; Kim J; Ju YJ; Kim HO; Yun CH; Cho JH
Front Immunol; 2020; 11():616898. PubMed ID: 33584707
[TBL] [Abstract][Full Text] [Related]
23. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.
Kirken RA; Erwin RA; Taub D; Murphy WJ; Behbod F; Wang L; Pericle F; Farrar WL
J Leukoc Biol; 1999 Jun; 65(6):891-9. PubMed ID: 10380915
[TBL] [Abstract][Full Text] [Related]
24. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
25. A profound deficiency in thymic progenitor cells in mice lacking Jak3.
Baird AM; Lucas JA; Berg LJ
J Immunol; 2000 Oct; 165(7):3680-8. PubMed ID: 11034372
[TBL] [Abstract][Full Text] [Related]
26. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.
Brown MP; Nosaka T; Tripp RA; Brooks J; van Deursen JM; Brenner MK; Doherty PC; Ihle JN
Blood; 1999 Sep; 94(6):1906-14. PubMed ID: 10477719
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness.
Selliah N; Finkel TH
J Immunol; 1998 Jun; 160(12):5697-701. PubMed ID: 9637477
[TBL] [Abstract][Full Text] [Related]
28. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
29. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.
Chen M; Cheng A; Chen YQ; Hymel A; Hanson EP; Kimmel L; Minami Y; Taniguchi T; Changelian PS; O'Shea JJ
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6910-5. PubMed ID: 9192665
[TBL] [Abstract][Full Text] [Related]
30. Jak3 negatively regulates dendritic-cell cytokine production and survival.
Yamaoka K; Min B; Zhou YJ; Paul WE; O'shea JJ
Blood; 2005 Nov; 106(9):3227-33. PubMed ID: 16020505
[TBL] [Abstract][Full Text] [Related]
31. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
Miyatake S; Sakuma M; Saito T
Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
[TBL] [Abstract][Full Text] [Related]
32. Critical sites for the interaction between IL-2Rgamma and JAK3 and the following signaling.
Tang W; Huo H; Zhu J; Ji H; Zou W; Xu L; Sun L; Zheng Z; Theze J; Liu X
Biochem Biophys Res Commun; 2001 May; 283(3):598-605. PubMed ID: 11341766
[TBL] [Abstract][Full Text] [Related]
33. Critical role for the common cytokine receptor gamma chain in intrathymic and peripheral T cell selection.
DiSanto JP; Guy-Grand D; Fisher A; Tarakhovsky A
J Exp Med; 1996 Mar; 183(3):1111-8. PubMed ID: 8642253
[TBL] [Abstract][Full Text] [Related]
34. Stat5a/b are essential for normal lymphoid development and differentiation.
Yao Z; Cui Y; Watford WT; Bream JH; Yamaoka K; Hissong BD; Li D; Durum SK; Jiang Q; Bhandoola A; Hennighausen L; O'Shea JJ
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1000-5. PubMed ID: 16418296
[TBL] [Abstract][Full Text] [Related]
35. Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3.
Säemann MD; Diakos C; Kelemen P; Kriehuber E; Zeyda M; Böhmig GA; Hörl WH; Baumruker T; Zlabinger GJ
Am J Transplant; 2003 Nov; 3(11):1341-9. PubMed ID: 14525593
[TBL] [Abstract][Full Text] [Related]
36. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
Gurniak CB; Berg LJ
Blood; 1996 Apr; 87(8):3151-60. PubMed ID: 8605329
[TBL] [Abstract][Full Text] [Related]
37. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ
J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533
[TBL] [Abstract][Full Text] [Related]
38. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
39. [Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro].
Zhao SM; Gu XC; Chang NB; Xu XD; Peng MT
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1701-5. PubMed ID: 16854326
[TBL] [Abstract][Full Text] [Related]
40. Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases.
Cetkovic-Cvrlje M; Uckun FM
Arch Immunol Ther Exp (Warsz); 2004; 52(2):69-82. PubMed ID: 15179321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
